Indian drug developer Hetero said on Monday it has received emergency use approval from the country’s health authorities to make a generic version of Roche Holding AG’s COVID-19 drug.
Indian drug developer Hetero said on Monday it has received emergency use approval from the country’s health authorities to make a generic version of Roche Holding AG’s COVID-19 drug.